Cargando…

MatchTope: A tool to predict the cross reactivity of peptides complexed with Major Histocompatibility Complex I

The therapeutic targeting of the immune system, for example in vaccinology and cancer treatment, is a challenging task and the subject of active research. Several in silico tools used for predicting immunogenicity are based on the analysis of peptide sequences binding to the Major Histocompatibility...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendes, Marcus Fabiano de Almeida, de Souza Bragatte, Marcelo, Vianna, Priscila, de Freitas, Martiela Vaz, Pöhner, Ina, Richter, Stefan, Wade, Rebecca C., Salzano, Francisco Mauro, Vieira, Gustavo Fioravanti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650389/
https://www.ncbi.nlm.nih.gov/pubmed/36389840
http://dx.doi.org/10.3389/fimmu.2022.930590
_version_ 1784828006255034368
author Mendes, Marcus Fabiano de Almeida
de Souza Bragatte, Marcelo
Vianna, Priscila
de Freitas, Martiela Vaz
Pöhner, Ina
Richter, Stefan
Wade, Rebecca C.
Salzano, Francisco Mauro
Vieira, Gustavo Fioravanti
author_facet Mendes, Marcus Fabiano de Almeida
de Souza Bragatte, Marcelo
Vianna, Priscila
de Freitas, Martiela Vaz
Pöhner, Ina
Richter, Stefan
Wade, Rebecca C.
Salzano, Francisco Mauro
Vieira, Gustavo Fioravanti
author_sort Mendes, Marcus Fabiano de Almeida
collection PubMed
description The therapeutic targeting of the immune system, for example in vaccinology and cancer treatment, is a challenging task and the subject of active research. Several in silico tools used for predicting immunogenicity are based on the analysis of peptide sequences binding to the Major Histocompatibility Complex (pMHC). However, few of these bioinformatics tools take into account the pMHC three-dimensional structure. Here, we describe a new bioinformatics tool, MatchTope, developed for predicting peptide similarity, which can trigger cross-reactivity events, by computing and analyzing the electrostatic potentials of pMHC complexes. We validated MatchTope by using previously published data from in vitro assays. We thereby demonstrate the strength of MatchTope for similarity prediction between targets derived from several pathogens as well as for indicating possible cross responses between self and tumor peptides. Our results suggest that MatchTope can enhance and speed up future studies in the fields of vaccinology and cancer immunotherapy.
format Online
Article
Text
id pubmed-9650389
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96503892022-11-15 MatchTope: A tool to predict the cross reactivity of peptides complexed with Major Histocompatibility Complex I Mendes, Marcus Fabiano de Almeida de Souza Bragatte, Marcelo Vianna, Priscila de Freitas, Martiela Vaz Pöhner, Ina Richter, Stefan Wade, Rebecca C. Salzano, Francisco Mauro Vieira, Gustavo Fioravanti Front Immunol Immunology The therapeutic targeting of the immune system, for example in vaccinology and cancer treatment, is a challenging task and the subject of active research. Several in silico tools used for predicting immunogenicity are based on the analysis of peptide sequences binding to the Major Histocompatibility Complex (pMHC). However, few of these bioinformatics tools take into account the pMHC three-dimensional structure. Here, we describe a new bioinformatics tool, MatchTope, developed for predicting peptide similarity, which can trigger cross-reactivity events, by computing and analyzing the electrostatic potentials of pMHC complexes. We validated MatchTope by using previously published data from in vitro assays. We thereby demonstrate the strength of MatchTope for similarity prediction between targets derived from several pathogens as well as for indicating possible cross responses between self and tumor peptides. Our results suggest that MatchTope can enhance and speed up future studies in the fields of vaccinology and cancer immunotherapy. Frontiers Media S.A. 2022-10-28 /pmc/articles/PMC9650389/ /pubmed/36389840 http://dx.doi.org/10.3389/fimmu.2022.930590 Text en Copyright © 2022 Mendes, de Souza Bragatte, Vianna, de Freitas, Pöhner, Richter, Wade, Salzano and Vieira https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Mendes, Marcus Fabiano de Almeida
de Souza Bragatte, Marcelo
Vianna, Priscila
de Freitas, Martiela Vaz
Pöhner, Ina
Richter, Stefan
Wade, Rebecca C.
Salzano, Francisco Mauro
Vieira, Gustavo Fioravanti
MatchTope: A tool to predict the cross reactivity of peptides complexed with Major Histocompatibility Complex I
title MatchTope: A tool to predict the cross reactivity of peptides complexed with Major Histocompatibility Complex I
title_full MatchTope: A tool to predict the cross reactivity of peptides complexed with Major Histocompatibility Complex I
title_fullStr MatchTope: A tool to predict the cross reactivity of peptides complexed with Major Histocompatibility Complex I
title_full_unstemmed MatchTope: A tool to predict the cross reactivity of peptides complexed with Major Histocompatibility Complex I
title_short MatchTope: A tool to predict the cross reactivity of peptides complexed with Major Histocompatibility Complex I
title_sort matchtope: a tool to predict the cross reactivity of peptides complexed with major histocompatibility complex i
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650389/
https://www.ncbi.nlm.nih.gov/pubmed/36389840
http://dx.doi.org/10.3389/fimmu.2022.930590
work_keys_str_mv AT mendesmarcusfabianodealmeida matchtopeatooltopredictthecrossreactivityofpeptidescomplexedwithmajorhistocompatibilitycomplexi
AT desouzabragattemarcelo matchtopeatooltopredictthecrossreactivityofpeptidescomplexedwithmajorhistocompatibilitycomplexi
AT viannapriscila matchtopeatooltopredictthecrossreactivityofpeptidescomplexedwithmajorhistocompatibilitycomplexi
AT defreitasmartielavaz matchtopeatooltopredictthecrossreactivityofpeptidescomplexedwithmajorhistocompatibilitycomplexi
AT pohnerina matchtopeatooltopredictthecrossreactivityofpeptidescomplexedwithmajorhistocompatibilitycomplexi
AT richterstefan matchtopeatooltopredictthecrossreactivityofpeptidescomplexedwithmajorhistocompatibilitycomplexi
AT waderebeccac matchtopeatooltopredictthecrossreactivityofpeptidescomplexedwithmajorhistocompatibilitycomplexi
AT salzanofranciscomauro matchtopeatooltopredictthecrossreactivityofpeptidescomplexedwithmajorhistocompatibilitycomplexi
AT vieiragustavofioravanti matchtopeatooltopredictthecrossreactivityofpeptidescomplexedwithmajorhistocompatibilitycomplexi